The FDA has expanded the approval of the Freespira Breathing System to include the treatment of panic disorder and PTSD in adolescents aged 13 to 17 years.

Around 13 percent of American adults regularly take an antidepressant, according to 2020 data, the most common of which are ...

FDA Commissioner Dr. Marty Makary said Thursday that the United States needs to transform its health care approach from treating disease to preventing it, as the Trump administration unveiled a ...

For the nearly 30 percent of major depressive disorder patients who are resistant to treatment, ketamine provides some amount of normalcy, but it requires frequent treatment and can have side effects.

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally ...

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally ...

Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in ...

Researchers have developed a machine learning–based model that can stratify the risk for postpartum depression directly after delivery.

Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.

An independent analysis found virtual mental health solutions for depression and anxiety effectively treat the conditions, ...

But there's no denying that it's seen a surge of interest in recent years. Ketamine clinics—or treatment centers that offer infusions of the drug—have popped up all over the country, not to mention on ...

Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression. The National Institutes of Health (NIH) published research in June 2024 that ...